JPRN-C000000042已完成2 期
A phase II study of percutaneous trans-esophageal gastric tubing for malignant gastrointestinal obstruction (JIVROSG-0205) - Percutaneous trans-esophageal gastric tubing (JIVROSG-0205)
Japan Interventional Radiology in Oncology Study Group (JIVROSG)0 个研究点目标入组 33 人开始时间: 2005年8月6日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 33
研究概览
简要总结
Technical success rate: 100% Average required time for procedure: 28.5 min Clinical efficacy: 91% Mortality within 30 days: 5 (All caused by progression of primary disease) Procedure related Adverse events (>Grade 2): Broncho-esophageal fistula
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Tracheostomy. 2) Intestinal obstruction due to the lesions between transverse colon and rectum. 3) Pregnancy. 4) Local therapy for neck region
研究者
相似试验
已完成
2 期
A phase II study of palliative treatment with metallic stents for inoperable malignant colorectal strictures. (JIVROSG-0206)Inoperable malignant colorectal strictures.JPRN-C000000044Japan Interventional Radiology in Oncology Study Group (JIVROSG)33
已完成
不适用
Prospective feasibility study on the efficacy and safety of the novel spiral dilator for EUS-guided drainagebiliary obstruction, cholecystitis, pancreatic duct obstruction, abcessJPRN-UMIN000046410Sendai City Medical Center10
已完成
不适用
Phase II study evaluating safety of transoral surgery assisted by a flexible-tip rigid endoscope for T1/2 laryngopharyngeal cancerT1/2 laryngopharyngeal squamous cell carcinomaJPRN-UMIN000019163Aichi Cancer Center Central Hospital20
已完成
2 期
Phase 2 study evaluating the efficacy and safety of the combination of Bendamustine, Rituximab and Dexamethazone (RBenda-D) for treatment of CD20-positive relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.Relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.JPRN-UMIN000008145Kyoto Prefectural University of Medicine/K-LSG33
Unknown
不适用
Phase II Clinical Trial for the Evaluation of the Efficacy of Transanal TMERectal CancerNCT02406118National Cancer Center, Korea49